The binding of Bandeiraea simplicifolia lectin-I isolectin B 4 on the endogenous glycoproteins of different insect cell lines led us to characterize for the first time a UDP-Gal:Gal␤1-3GalNAc ␣1,4-galactosyltransferase in a Mamestra brassicae cell line (Mb). The study of the acceptor specificity indicated that the Mb ␣-galactosyltransferase prefers Gal␤1-3-R as acceptor, and among such glycans, the relative substrate activity V max /K m was equal to 20 l⅐mg ؊1 ⅐h ؊1 for Gal␤l-3Glc-NAc␤1-O-octyl and to 330 l⅐mg ؊1 ⅐h ؊1 for Gal␤1-3Gal-NAc␣-1-O-benzyl, showing clearly that Gal␤1-3GalNAc disaccharide was the more suitable acceptor substrate for Mb ␣-galactosyltransferase activity. Nuclear magnetic resonance and mass spectrometry data allowed us to establish that the Mb ␣-galactosyltransferase synthesizes one unique product, Gal␣1-4Gal␤1-3GalNAc␣1-Obenzyl. The Gal␤1-3GalNAc disaccharide is usually present on O-glycosylation sites of numerous asialoglycoproteins and at the nonreducing end of some glycolipids. We observed that Mb ␣1,4-galactosyltransferase catalyzed the transfer of galactose onto both natural acceptors. Finally, we demonstrated that the trisaccharide Gal␣1-4Gal␤1-3GalNAc␣1-O-benzyl was able to inhibit anti-P K monoclonal antibody-mediated hemagglutination of human blood group P K 1 and P K 2 erythrocytes.
In recent years, the development of therapeutic glycoprotein production using the baculovirus expression system in insect cells (1) (2) (3) (4) has stimulated concerns to determine the posttranslational modifications capacity, in particular the glycosylation potential of insect cells. In fact, it is now well established that protein-bound carbohydrate side chains play important roles on the physicochemical properties and functions of glycoproteins such as antigenicity, immunogenicity, and metabolic clearance (5) (6) (7) (8) .
The N-glycosylation pattern of recombinant glycoproteins expressed by lepidopteran cells using the baculovirus vector is now well documented and revealed that the N-linked oligosaccharides found are essentially of high mannose type (Man 9 -5 GlcNAc 2 ) and short truncated structures (Man 3-2 (Fuc 0 -1 )GlcNAc 2 )
1 frequently substituted by a Fuc residue ␣1,6-linked to the asparagine-bound GlcNAc residue (9 -24) . Only a few studies have shown complex N-linked glycans in insect cells. Recent data suggest that the insect cell lines Estigmena acrea and Trichoplusia ni clone Tn-5-B14 (Tn) can add some terminal galactose residues to the recombinant human interferon ␥ and to the heavy chain of a heterologous murin IgG (25, 26) , respectively. Only one group has reported that recombinant human plasminogen carries complex type N-glycans with terminal sialic acid residues when expressed in Spodoptera frugiperda clone Sf-21 (Sf-21) or Mamestra brassicae clone SPCMb-92-C6 (Mb) (27) (28) (29) .
As mainly observed on recombinant glycoproteins expressed by the baculovirus/insect cell system, endogenous N-glycan structures found in insect cell glycoproteins have no complex type glycans (16, 30 -32) , but a small amount of oligosaccharides contain terminal GlcNAc or GalNAc residues (33) (34) (35) . Activity measurements of several glycosyltransferases involved in the addition of terminal sugars to N-linked oligosaccharides have demonstrated that lepidopteran cells contain ␣1,6-fucosyltransferase (36) and a low level of ␤1,2-N-acetylglucosaminyltransferase I (37, 38) but lack ␤1,4-galactosyltransferase and sialyltransferase activities.
Compared with the information available on the structure and biosynthesis of lepidopteran N-glycans, our knowledge about the synthesis of O-linked oligosaccharides remains rather poor. A comparison of O-glycans on recombinant pseudorabies virus envelope protein gp50 expressed in S. frugiperda clone Sf-9 (Sf-9), Vero and Chinese hamster ovary cells has shown that the protein synthesized by both mammalian cell lines contained exclusively the core 1 disaccharide Gal␤1-3GalNAc (T-antigen) mainly substituted by one or two sialic acid residues. On the other hand, most of the O-glycosylation sites of insect-produced protein were only substituted by GalNAc residues, forming Tn-antigen. The Sf-9 cell line also synthesized Gal␤1-3GalNAc but in very low amounts, and none of these O-glycans are substituted by sialic acid residues (39) . A characterization of the O-linked oligosaccharidic structures on * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
ʈ To whom correspondence should be addressed: a chimeric respiratory syncytial virus protein as well as on a human interleukin-2 with artificially introduced O-glycosylation sites, expressed in Sf-9 and Sf-21 cells, respectively, yielded similar results; only GalNAc and Gal␤1-3GalNAc were found (15, 18) . Measurement of the two relevant O-glycosyltransferase activities performed in Sf-9, Vero, and Chinese hamster ovary cells has revealed that, even if the three cell lines expressed a comparable level of polypeptide N-acetylgalactosaminyltransferase activity, there were high variations in core 1 ␤1,3-Gal-T activity, with Sf-9 cells containing the lowest level (39) .
In summary, the determination of the glycosylation potential of lepidopteran cells achieved through the measurement of the different glycosyltransferase activities, as well as through the identification of the N-and O-glycan structures present on endogenous insect cell glycoproteins or on recombinant glycoproteins expressed by the baculovirus/insect cell system, showed that the glycosylation potential of insect cell lines is deficient in comparison with mammalian cells. Since N-and O-glycan structures found on the insect recombinant glycoproteins are often different from those occurring in the corresponding natural glycoproteins, the aberrant glycosylation pattern can limit the development of the therapeutic glycoprotein production in lepidopteran cells using the baculovirus expression system. Indeed, these changes in glycosylation can cause a decrease of the half-life of the recombinant glycoproteins after blood injection (8, 40) or induce an immunogenic response against normally cryptic peptide epitopes (41-43) but also against glycan epitopes normally absent in humans.
It is clear that some oligosaccharide epitopes present on glycoproteins or glycolipids expressed at the cell surface of most mammalian species cause a rapid rejection after exposure to human blood. The major element responsible for such human rejection has been identified as a unique carbohydrate structure, the ␣-galactosyl epitope Gal␣1-3Gal (44 -45) . Indeed, as much as 1% of the circulating human IgG were found to interact with Gal␣1-3Gal epitopes, both on glycoproteins (46 -47) and on glycosphingolipids (48 -50) .
Because the ␣-galactosyl epitope is strongly antigenic in humans, it was particularly interesting to look for such carbohydrate epitopes on endogenous insect cell glycoproteins, since the glycosylation patterns of the expressed glycoproteins are determined to a large extent by the host cell glycosylation machinery. For that purpose, after electrophoresis and Western blotting of noninfected insect cell homogenates, we have tested the affinity of the insect glycoproteins for an ␣Gal-specific lectin, B. simplicifolia lectin-I isolectin B 4 (BSI-B 4 ), which strongly recognizes Gal␣1-3/4Gal sequences (51) (52) (53) ; demonstrated the binding of BSI-B 4 to insect cell glycoproteins, especially to Mb endogenous glycoproteins; and characterized a new UDP-Gal:Gal␤1-3GalNAc ␣1,4-galactosyltransferase (␣1,4-Gal-T) activity specific to Gal␤1-3GalNAc acceptor substrates in these cells.
EXPERIMENTAL PROCEDURES
Materials-All reagents were of analytical grade. UDP- H]Gal (650 GBq⅐mmol
Ϫ1
) was purchased from Amersham Pharmacia Biotech and used after dilution with nonradioactive nucleotide sugar from Sigma. Peroxidase-labeled BSI-B 4 , 3,3Ј-diaminobenzidine tetrahydrochloride tablets, insoluble peroxidase substrate, BSI-B 4 , G M1a , G A1 , G D1b , Gal␤l-3GalNAc␣1-O-bn, lactose (Gal␤1-4Glc), Gal, Gal␣1-p-nitrophenol, Gal␤1-p-nitrophenol, Gal␣1-O-methyl, fetuin, angiotensin I, and Triton X-100 were purchased from Sigma. N-Acetyllactosamine (Gal␤1-4GlcNAc) and N-acetyl-isolactosamine (Gal␤1-3GlcNAc) were from Calbiochem. Lacto-N-tetraose (Gal␤1-3GlcNAc␤1-3Gal␤1-4Glc) and lacto-N-neotetraose (Gal␤1-4GlcNAc␤1-3Gal␤1-4Glc) were prepared from bovine colostrum (54) . Lactosylceramide was the generous gift of Dr. J.-F. Bouhours (INSERM U-437, Nantes, France). Gal␤l-
Gal␤l-3GlcNAc␤1-O-octyl, and Gal␤l-4GlcNAc␤1-O-bn were generous gifts of Dr. C. Augé (URA CNRS 462, Orsay, France). Asialofetuin was prepared by mild acid hydrolysis of fetuin. The sugar composition of desialylated compounds was controlled by gas chromatography after methanolysis and trimethylsililation. Dowex 1 ϫ 2 (Cl Ϫ form, 100 -200 mesh), Bio-Gel P-2 (200 -400 mesh), and P-4 (200 -400 mesh) were purchased from Bio-Rad (Ivry-sor-Seine, France). The Sep-Pak C 18 cartridge was purchased from Waters Corp. (Milford, MA). Nitrocellulose membrane BioTrace NT was from Gelman Sciences. Murine monoclonal antibodies anti-P 1 , anti-P k , and anti-P and red blood cells from individuals typed in the P/P 1 blood group system were from the Institut National de la Transfusion Sanguine (Paris, France).
Insect 2 The three cell lines were adapted, maintained, and cultivated at 28°C in EX-CELL 401™ (Sera-Lab, Blackthorn, United Kingdom), a semidefined medium for the serum-free culture of lepidopteran insect cells.
Cells were harvested at confluence, and cell homogenates were prepared by lysing the cells at 0°C with 10 mM sodium cacodylate buffer, pH 6.5, containing 1% Triton X-100, 20% glycerol, 0.5 mM dithiothreitol, and 5 mM MnCl 2 (1 ml/3 ϫ 10 7 cells). After a 10-min incubation under continuous stirring, cell homogenates were centrifuged at 10,000 ϫ g for 15 min, and the supernatants were used for SDS-polyacrylamide gel electrophoresis. Protein concentration was determined according to the method described by Peterson (56) using bovine serum albumin as a standard.
Electrophoresis and Western Blotting-SDS-polyacrylamide gel electrophoresis was performed under reducing conditions on 4 -20% gradient polyacrylamide gel (57) using 40 g of protein/lane for each cell homogenates. After migration, proteins were transferred to a nitrocellulose membrane as described by Vaessen et al. (58) . The blot was then separated in two parts and treated with polyvinylpyrolidone (2% in Tris-buffered saline (Tris/HCl 10 mM, NaCl 0.15 M, pH 7.4)) prior the incubation with the peroxidase-labeled BSI-B 4 (2 g⅐ml Ϫ1 in Tris-buffered saline containing 1 mM MgCl 2 , 1 mM MnCl 2 , 1 mM CaCl 2 ) with or without 0.5 M Gal␣1-O-methyl used as a competitor. After washing, labeled glycoproteins were revealed according to the Sigma Fast Staining protocol using 3,3Ј-diaminobenzidine tetrahydrochloride and urea/H 2 O 2 .
Enzymatic Assay-2 ϫ 10 8 Mb cells cultured in EX-CELL 401™ were lysed by ultrasonication (5-s pulsed at 0°C in 10 ml 0.25 M sucrose, 0.2 M NaCl solution). Microsome suspensions were prepared by centrifugation as described previously (59) and stored at Ϫ80°C in NaCl/sucrose solution until use.
Assays were performed at least in duplicate. The incorporation of [6- 3 H]Gal was determined by subtraction of the radioactivity measured in the absence of exogenous acceptors, and results were expressed as average values as nmol of Gal residues transferred/mg of protein/h.
Microsomal fractions (35 g of protein) were brought to a final volume of 50 l with 0.125 M Mes, pH 7.0, 0.15% Triton X-100, 5 mM ␥-galactonolactone, 10 mM ATP, 12.5 mM MnCl 2 , 1 mM UDP- [6- 3 H]Gal (235 MBq⅐mmol Ϫ1 ; 11.75 kBq/50 l), containing 4 mM of oligosaccharide or aryl glycoside, 1 mM of ganglioside, or 2 mg⅐ml Ϫ1 of glycoprotein acceptor and incubated for 1 h at 37°C.
Reaction products were separated from UDP-[ 3 H]Gal depending on the acceptor substrate. For oligosaccharide acceptors, assay mixtures were diluted to 0.5 ml with H 2 O to stop the reaction, and the amount of incorporated [
3 H]Gal was determined by ion exchange chromatography on a 1-ml Dowex 1 ϫ 2 column (Cl Ϫ form, 100 -200 mesh) equilibrated in water. The radioactivity of the corresponding products was detected by scintillation counting (60) . For glycoproteins, reactions were stopped by adding 1 ml of ice-cold phosphotungstic acid (5% in 2 M HCl). Precipitates were collected on glass fiber filters, washed extensively with 5% trichloroacetic acid, distilled water, and ethanol, and processed for scintillation counting (60) . For aryl glycosides and glycolipids, the reactions were stopped by adding 1 volume of ethanol. Samples were centrifuged at 3000 ϫ g for 5 min, and supernatants were applied to a Sep-Pak C 18 cartridge. After washing with 5 ml of water, aryl glycosides were eluted with 5 ml of 30% acetonitrile in water and glycolipids with 2 ml of CH 3 OH, followed by a 5-ml elution with CHCl 3 /CH 3 OH (1:1, v/v) and processed for scintillation counting. The rates of all reactions were linear with time, at least for 1 h. For kinetic analysis, incubations were performed for 1 h using various concentrations (0.125-4 mM) of Gal␤l-3GalNAc␣1-O-bn and Gal␤l-3GlcNAc␤1-O-octyl.
Large Scale Preparation of the Galactosylated Product of Gal␤1-3GalNAc␣1-O-bn-Mb microsomal fractions (850 g of protein)
were brought to a final volume of 600 l in conditions described above with 4 mM UDP- [6- 3 H]Gal (62 MBq⅐mmol
Ϫ1
; 0.148 MBq/600 l), 4 mM of Gal␤l-3GalNAc␣1-O-bn and incubated for 24 h at 37°C. The incubation mixture was applied to a Sep-Pak C 18 cartridge, eluted as described previously, and lyophilized. Aliquots of the incubation mixture (5 l) were collected after 0, 2, 4, 8, and 24 h and assayed for radioactivity (data not shown). The yield of transfer after 24 h of incubation was 66% (ϳ970 g of galactosylated product). The purified product was further analyzed by NMR and mass spectrometry (MS).
For the immunoreactivity study, we produced 4 mg of that compound with 90% of purity. That large scale preparation was performed as described above, in a final volume of 1.85 ml (1.4 mg of Mb microsomal proteins) and incubated for 48 h at 37°C.
Two-dimensional Homonuclear and Heteronuclear NMR Spectroscopy-1 H-NMR spectroscopy was performed on a Brü ker ASX 400WB spectrometer. Chemical shifts are expressed in ppm downfield from internal sodium 4,4Ј-dimethyl-4-silapentane-1-sulfonate but were actually measured by reference to internal acetone (␦ ϭ 2.225 ppm in D 2 O at 25°C). The two-dimensional homonuclear correlation spectroscopy (COSY), with simple and double relay transfer, and the heteronuclear multiple-quantum coherence spectroscopy (HMQC) spectroscopy experiments were performed using Brü ker standard pulse-sequences.
Matrix-assisted Laser Desorption Mass Spectrometry (MALD-MS) and Gas Chromatography-Mass Spectrometry (GC-MS)-100
g of the galactosylated product were permethylated according to Ciucanu and Kerek (61) prior to MALD-MS analysis. The methylated compound was then methanolyzed, and the formed methylglycosides were analyzed by GC-MS after peracetylation as described by Fournet et al. (62) .
Molecular weight of the permethylated galactosylated product was measured by MALD-MS on a Vision 2000 time-of-flight mass spectrometer (Finnigan MAT, Bremen, Germany) equipped with a 337-nm UV laser. The mass spectra were acquired in reflectron mode under 6-kV acceleration voltage and positive detection. The sample was prepared by mixing directly onto the target 1 l of the analyte solution (typically 50 pmol) and 1 l of a 2,5-dihydroxybenzoic acid matrix solution (12 mg⅐ml Ϫ1 in CH 3 OH/H 2 O, 70:30) and then allowed to crystallize at room temperature. External calibration was performed using an angiotensin I standard (M r ϭ 1296.7). 10 shots were accumulated for the mass spectrum.
GC separation of partially methylated and acetylated methylmonosaccharides from galactosylated product was performed on a fused silica capillary column from SGE (0.32 mm x 25 m) using helium as carrier gas at pressure of 0.5 bar with the following temperature program (110 -240°C at 3°C/min). The GC-MS analyzer (Delsi DI 700 gas chromatograph) was coupled with a Nermag R10 -10 mass spectrometer (Rueil Malmaison, France) using an electron energy of 70 eV and an ionizing current of 0.2 mA.
Release of H]Gal-labeled Oligosaccharides from AsialofetuinAsialofetuin (1.25 mg, 5 mg⅐ml Ϫ1 final concentration) was incubated for 24 h at 37°C under the conditions described above with Mb microsomal fraction (210 g of protein) and 0. 3 H-labeled asialofetuin sample was submitted to alkaline treatment under reducing conditions in 0.1 M NaOH containing 1 M NaBH 4 for 48 h at 45°C (63) . At the end of the incubation time, the sample was acidified at pH 6 by addition of Dowex 50 ϫ 8 (H ϩ form, 20 -50 mesh) and evaporated. The sample was then resuspended in methanol and evaporated three times, dissolved in water, and applied to a Bio-Gel P4 column (80 ϫ 1.2 cm, 200 -400 mesh) equilibrated in 0.1 M pyridine acetate pH 5.6, to separate released O-glycans from N-glycopeptides.
Immunoreactivity of Gal␣1-4Gal␤1-3GalNAc␣-O-bn-Monoclonal antibodies anti-P 1 , anti-P k , anti-P, and BSI-B 4 were previously tested by agglutination assays using 0.7% (by volume) suspensions of papaintreated P 1 , P k 1 , P k 2 , and p (Tja Ϫ ) human red cells, for 7 min at 37°C, in sodium phosphate buffer, pH 6.8, containing 150 mM NaCl. This agglutinant system titration allowed to control the specificity of reagents and to determine the correct concentration needed for each antibody or lectin, in order to perform the inhibition assays with both aryl glycosides Gal␤1-3GalNAc␣1-O-bn and Gal␣1-4Gal␤1-3GalNAc␣1-O-bn. Then the monoclonal antibodies and the BSI-B 4 at the appropriate dilution were incubated for 4 h at 22°C in a final volume of 20 l with a serial dilution of Gal␤1-3GalNAc␣1-O-bn or Gal␣1-4Gal␤1-3Gal-NAc␣1-O-bn. The mixtures were further tested as described above by agglutination assays against 20 l of papain-treated P 1 , P k 1 , or P k 2
erythrocytes.
RESULTS

BSI-B 4 Binds to Mb
Glycoproteins-40 g of cellular glycoproteins from Sf-9, Mb, or Tn cultured in EX-CELL 401™ medium were fractionated by SDS-polyacrylamide gel electrophoresis and revealed with peroxidase-labeled BSI-B 4 . As indicated in Fig. 1 , the three lepidopteran cell lines expressed glycoproteins recognized by BSI-B 4 . The specificity of the binding of the lectin was shown by the total absence of staining observed when BSI-B 4 was incubated in the presence of 0.5 M Gal␣1-O-methyl used as a competitor.
The pattern of expression of revealed bands was dependent on the cell line, showing that the higher staining intensity was obtained with Mb glycoproteins. In Mb, a 100 -110-kDa band was strongly revealed by BSI-B 4 compared with Sf-9 or Tn in which the staining was of a lower intensity. In Sf-9, BSI-B 4 revealed a large 95-105-kDa band with two other weak signals at 85 and 190 kDa. Tn glycoprotein staining was observed between 95 and 120 kDa with a main signal at 100 -110 kDa. According to the specificity of BSI-B 4 , which recognizes Gal␣1-3/4Gal sequences (51-53), these data indicated the presence of ␣-Gal residues in terminal position of endogenous high molecular weight glycoproteins of Sf-9, Mb, and Tn, reflecting the activity of an ␣-galactosyltransferase in these cell lines. Because the strongest binding was observed on Mb glycoproteins, we have focused our interest on this cell line in order to characterize the activity of the galactosyltransferase responsible for the biosynthesis of these structures.
Mb Preferentially Transfers Galactose onto the Terminal Position of Gal␤1-3GalNAc Sequence-To characterize the substrate specificity of the putative ␣-galactosyltransferase activity, we incubated microsomes with various potential acceptors containing a terminal galactose residue. As indicated in Table I, methyl, a synthetic substrate that was previously shown to be a good acceptor for the transfer of sialic acid residues in ␣2,3-linkage to terminal Gal (64) . The microsomal fraction of Mb also transferred galactose residue onto N-acetylisolactosamine (Gal␤l-3GlcNAc) or Gal␤l-3GlcNAc␤1-O-octyl but with a lower yield (36.9 and 39.9%, respectively) compared with Gal␤1-3GalNAc␣1-O-bn. As indicated in Table I , the transfer of galactose residues to N-acetyllactosamine (Gal␤l-4GlcNAc) or to lacto-N-neotetraose (Gal␤l-4GlcNAc␤1-3Gal␤1-4Glc) was 2.7-or 1.5-fold lower than for N-acetylneolactosamine (Gal␤l-3GlcNAc) or lacto-N-tetraose (Gal␤l-3GlcNAc␤1-3Gal␤1-4Glc), respectively. A similar difference was observed between Gal␤l-4GlcNAc␤1-O-bn and Gal␤l-3GlcNAc␤1-O-octyl, showing that Mb ␣-galactosyltransferase preferred Gal␤1-3-R over Gal␤1-4-R acceptor substrates. A small amount of galactose residues was transferred to lactose (Gal␤l-4Glc), but Gal or ␣-and ␤-arylglycosides of Gal were not acceptor substrates for that enzymatic activity. According to these data, it appeared that the substrate specificity of Mb ␣-galactosyltransferase activity completely differed from UDP-Gal:Gal␤1-4GlcNAc ␣1,3-galactosyltransferase previously purified and cloned from different cell lines (65) (66) (67) .
Since both Gal␤1-3GalNAc and Gal␤1-3GlcNAc sequences appeared to be acceptor substrates for Mb ␣-galactosyltransferase activity, we further compared the kinetic parameters of transfer of galactose residues by Mb microsomal fraction using Gal␤1-3GalNAc␣-1-O-bn and Gal␤l-3GlcNAc␤1-O-octyl as acceptors. As shown on Table II, the K m value for Gal␤1-3Gal-NAc␣-1-O-bn was 11-fold lower compared with Gal␤l-3Glc-NAc␤1-O-octyl. In addition, the relative substrate activity V max /K m was equal to 20 l⅐mg Ϫ1 ⅐h Ϫ1 for Gal␤l-3GlcNAc␤1-Ooctyl and to 330 l⅐mg Ϫ1 ⅐h Ϫ1 for Gal␤1-3GalNAc␣-1-O-bn, showing undoubtedly that Gal␤1-3GalNAc disaccharide is the most suitable acceptor substrate for Mb ␣-galactosyltransferase activity.
Galactose Residue Is ␣1,4-Linked at the Nonreducing Position of Gal␤1-3GalNAc-In order to precisely determine the linkage (anomery and substitution) of Gal transferred onto Gal␤1-3GalNAc by the Mb ␣-galactosyltransferase activity, NMR analysis was performed on the product of the transfer reaction onto Gal␤1-3GalNAc␣-1-O-bn (compound A) as acceptor (Table III and Fig. 2) . The main characteristics of the NMR spectrum of the acceptor are the signals relative to the terminal ␤-Gal unit, observed at ␦ ϭ 4.454 ppm (H-1), ␦ ϭ 3.620 ppm (H-3), and ␦ ϭ 3.900 ppm (H-4). By integration of the signals relative to terminal ␤-Gal IIA (␦H-1 ϭ 4.454 ppm) and substituted ␤-Gal IIB (␦H-1 ϭ 4.521 ppm) a ratio of 3:7 was measured, corresponding to an effective transfer of galactose reaching up to 70%. The new anomeric proton resonance observed at ␦ ϭ 4.949 ppm (J 1,2 ϳ3 Hz) is characteristic of the ␣-form of galactose, the conformation of which was confirmed by the set of its vicinal coupling constants J H1,H2 , J H2,H3 , and J H3,H4 . The downfield shift that affects the ␤-Gal IIB H-3 (⌬␦ ϭ ϩ0.072 ppm) and H-4 (⌬␦ ϭ ϩ0.125 ppm) resonance is in favor of an O-4 substitution of this sugar unit. This interpretation was confirmed by examination of the HMQC spectrum, which clearly shows two C-4 resonances at ␦ ϭ 70.20 ppm (terminal ␣-Gal IIIB ) and ␦ ϭ 78.47 ppm (O-4-substituted ␤-Gal IIB ).
On the basis of these observations, the structure of the neosynthesized compound was established as follows: Gal␣1-4Gal␤1-3GalNAc␣-1-O-bn (compound B).
The NMR result was confirmed by the MS analysis. The MALD-MS spectrum of the permethylated aryl glycosides (Fig.  3) showed only two predominant salted (Na ϩ or K ϩ ) molecules. The first pseudomolecular ions masses corresponded to the expected mass of the permethylated acceptor Gal␤1-3Gal-NAc␣ (Table IV) .
Activity of the UDP-Gal:Gal␤1-3GalNAc ␣1,4-Galactosyl- transferase toward Glycolipids and Asialoglycoproteins-We have determined the activity of Mb ␣1,4-Gal-T toward asialofetuin and several glycolipids. The concentration for asialofetuin was fixed to 2 mg⅐ml Ϫ1 , which corresponds to a final concentration in Gal␤1-3GalNAc equal to 0.13 mM, and the final concentration used for glycolipid assays was 1 mM. As indicated in Table V , among the five tested glycolipids, G M1a and G A1 were acceptors of Mb ␣1,4-Gal-T. A low transfer was also observed onto lactosylceramide, which can be correlated with the transfer obtained onto free lactose, and almost no transfer was observed onto G M2 , which possesses a GalNAc residue in the terminal position. Surprisingly, G D1b which has a Gal␤1-3GalNAc terminal sequence, was a poor acceptor substrate. This is probably due to a steric incompatibility between the ␣1,4-Gal-T and the ␣2,8-linked disialylated chain present on this glycolipid. In all cases, the relative activity of Mb ␣1,4-Gal-T toward glycolipids containing Gal␤1-3GalNAc terminal sequences was low compared with Gal␤l-3GalNAc␣1-O-bn (less than 10%). This weak activity could reflect that the transfer onto glycolipids requires specific incubation conditions different from those applied for oligosaccharides and aryl-glycosides. As related in Table V , despite the fact that terminal Gal␤1-3GalNAc was low in concentration in the asialofetuin assay (0.13 mM), the activity of transfer onto asialofetuin was 6.2 nmol⅐h Ϫ1 ⅐mg Ϫ1 . At the same concentration, the transfer onto Gal␤l-3GalNAc␣1-O-bn was approximately 30 nmol⅐h Ϫ1 ⅐mg
Ϫ1
and indicated that under these incubation conditions asialofetuin was a good acceptor substrate for the Mb ␣1,4-Gal-T.
Release of H]Gal-labeled Oligosaccharides from Asialofetuin-Asialofetuin (M r 45,500) contains three triantennary complex-type N-glycan chains with Gal␤1-4GlcNAc terminal sequence and three O-linked Gal␤1-3GalNAc␣1-O-Ser/Thr chains (68) . Therefore, 5 mg⅐ml Ϫ1 of asialofetuin in the reaction mixture allowed one to reach a concentration of terminal galactose acceptor sites equal to ϳ206 M for Gal␤1-3GalNAc-R and equal to ϳ618 M for Gal␤1-4GlcNAc-R terminal sequences. After 24 h of incubation at 37°C, 36.2% of the terminal galactose residues of asialofetuin were substituted with [ 3 H]Gal. In order to discriminate between [ 3 H]Gal added onto N-or O-glycans of asialofetuin, respectively, a reductive ␤-elimination was performed, and released O-oligosaccharides were separated from N-glycopeptides by fractionation on a Bio-Gel P4 column previously calibrated (Fig. 4) . Gel permeation resolved two main peaks, appearing at the elution volume of N-glycopeptides (arrow at position 1) and of O-linked glycans of asialofetuin (arrow at position 2), respectively. This experiment confirmed that ␣1,4-Gal-T activity expressed in the microsomal fraction of Mb transferred galactose onto glycoproteins containing terminal galactose residues. We observed that the transfer of [ 3 H]Gal was mainly onto O-oligosaccharides (74.7% of the transferred radioactivity) rather than onto the N-glycopeptides (25.3% of the transferred radioactivity). This result also indicated that 65.5% of the Gal␤1-3GalNAc terminal sequences were substituted by a Gal residue, while only 7.9% of the Gal␤1-4GlcNAc terminal sequences were occupied. These data confirmed that the Mb ␣1,4-Gal-T formed preferentially Gal␣1-4Gal␤1-3GalNAc␣1-O-Ser/Thr on asialofetuin.
Immunoreactivity of Gal␣1-4Gal␤1-3GalNAc␣-O-bn-The human blood group P system consists of five phenotypes, P 1 , P 2 , P k 1 , P k 2 , and p, depending on the presence or absence of the three antigens P (GalNAc␤1-3Gal␣1-4Gal␤1-4Glc␤1-ceramide), P k (Gal␣1-4Gal␤1-4Glc␤1-ceramide), and P 1 (Gal␣1-4Gal␤1-4GlcNAc␤1-3Gal␤1-4Glc␤1-ceramide). The red cells P 1 express P and P 1 antigens; the erythrocytes P k 1 express P k and P 1 antigens; and red cells P k 2 express only P k antigens. We have determined the minimum concentration of Gal␣1-4Gal␤1-3GalNAc␣1-O-bn able to inhibit human blood group P erythrocyte agglutination (Table VI) . Negative controls were previously performed using Gal␤1-3GalNAc␣1-O-bn, and as expected, no inhibition was observed. In contrast, Gal␣1-4Gal␤1-3GalNAc␣1-O-bn was able to inhibit the agglutination mediated by anti-P k mAbs (0.4 mM minimum concentration) and by BSI-B 4 (0.08 mM minimum concentration). However, the agglutination of P 1 erythrocytes mediated by both anti-P or anti-P 1 mAbs was not inhibited by the Gal␣1-4Gal␤1-3Gal-NAc␣1-O-bn.
DISCUSSION
In this paper, we demonstrated for the first time the occurrence of a UDP-Gal:Gal␤1-3GalNAc ␣1,4-galactosyltransferase, in a lepidopteran cell line. This observation is supported by several lines of evidence.
Western blot analysis of endogenous glycoproteins from Sf-9, Mb, and Tn have shown specific binding of BSI-B 4 onto high molecular weight glycoproteins, which differed from one cell line to another. The staining was particularly intense for a 100 -110-kDa band in Mb cells, and, according to the specificity of BSI-B 4 (51) (52) (53) , that fitted well with the presence of Gal␣1-3/4Gal terminal sequences in the glycoproteins of the different examined lepidopteran cell lines.
Based on that first observation, we focused our experiments on the characterization of an ␣-galactosyltransferase activity in Mb. The specificity of the glycosyltransferase activity responsible for the biosynthesis of the Mb ␣-Gal terminal sequences was studied using several acceptor substrates containing a terminal galactose residue. That choice took into account the specificity of BSI-B 4 and also the fact that the different ␣-galactosyltransferases characterized so far transferred Gal residue in ␣-linkage onto a terminal galactose to form the terminal disaccharides Gal␣1-3Gal (65) (66) (67) or Gal␣1-4Gal (69 -71) . Oligosaccharide substrates revealed that the Mb ␣-galactosyltransferase preferred the Gal␤1-3-R unit as acceptor (Table I) , and among such glycans, the relative substrate activity V max /K m shows that the Gal␤1-3GalNAc is the most suitable acceptor (Table II) .
To determine the nature of the linkage of the transferred Gal residue, we have performed a large scale preparation using Gal␤l-3GalNAc␣1-O-bn acceptor. NMR and MS data allowed us to establish that the Mb ␣-galactosyltransferase synthesized one unique product: Gal␣1-4Gal␤1-3GalNAc␣1-O-bn. The fact that only one product was formed, without any trace of ␤-linkage or of other substitution than onto the C-4 position of the galactose acceptor, leads us to conclude that Mb microsomes contained essentially a galactosyltransferase activity able to catalyze the addition of galactose residues ␣1,4-linked to Gal␤1-3GalNAc terminal sequences.
Gal␤1-3GalNAc disaccharide is usually present on O-glycosylation sites of numerous asialoglycoproteins but also on glycolipids, including G A1 , G M1a , or G D1b . We determined that Mb ␣1,4-Gal-T acted both on glycoproteins and glycolipids, although in our enzymatic assay the transfer onto glycolipids was low. Furthermore, we have confirmed that the Gal residue was added preferentially onto Gal␤1-3GalNAc␣1-O-Ser/Thr rather than onto Gal␤1-4GlcNAc sequence present in the terminal position of N-glycans of asialofetuin. Such a result is in agreement with the first observation of the binding of BSI-B 4 onto endogenous Mb glycoproteins.
Using a microsomal fraction as enzyme source, the presence of other galactosyltransferases using UDP-Gal as a donor substrate could not be excluded. Only one core 1 ␤1,3-galactosyltransferase (UDP-Gal:GalNAc␣1-O-Ser/Thr ␤1,3-galactosyltransferase) has been described in lepidopteran cells (39) , and the ␤1,4-galactosyltransferase (UDP-Gal:GlcNAc ␤1,4-galactosyltransferase) that adds a Gal residue onto N-glycan structures has never been detected in insect cells. Moreover, both enzymes did not use terminal Gal oligosaccharides as acceptors. Consequently, interference in ␣-galactosyltransferase assays was rather improbable, even if Mb microsomes may contain numerous different glycosyltransferases.
The high activity of the Mb ␣1,4-Gal-T allowed us to synthesize sufficient amounts of Gal␣1-4Gal␤1-3GalNAc␣1-O-bn to study the possible applications of that trisaccharidic epitope. Gal␣1-4Gal-specific mAbs are important tools for the characterization of tissues or isolated glycoconjugates (73) . We examined, therefore, the capacity of Gal␣1-4Gal␤1-3GalNAc␣1-O-bn to inhibit the agglutination of P 1 , P k 1 , or P k 2 red blood cells mediated by anti-P k , anti-P 1 , anti-P mAbs, or BSI-B 4 (Table VI) . Inhibition of hemagglutination assays showed that Gal␣1-4Gal␤1-3GalNAc␣-O-bn was recognized as a good competitor for anti-P k mAb, as well as for BSI-B 4 . As expected, Gal␣1-4Gal␤1-3GalNAc␣1-O-bn could not inhibit either the anti-P-mediated agglutination of P 1 erythrocytes or the anti-P 1 -mediated agglutination of P k 1 red blood cells. Such results were in agreement with previous results indicating that the anti-P k mAb recognized mainly the terminal disaccharide Gal␣1-4Gal, whereas anti-P 1 was specific for the terminal P 1 trisaccharide Gal␣1-4Gal␤1-4GlcNAc (74 -76) . In addition, the observation that Gal␣1-4Gal␤1-3GalNAc␣-O-bn strongly inhibited the BSI-B 4 -mediated hemagglutination fitted well with the binding of that lectin on Mb glycoproteins observed by Western blotting (Fig. 1) and favors the presence of such glycans in that insect cell line.
Interestingly, chemical and immunochemical studies have indicated that galabiosylceramide and P 1 and P k antigens are expressed in many pig and human tissues (73, (77) (78) (79) . In addition, several studies have shown that Gal␣1-4Gal-containing glycolipids act as receptors for the binding of pathogenic bacteria, such as Escherichia coli to human uroepithelial cells (79) and Streptococcus suis, which is responsible for meningitis in pigs and humans (80, 81) . Gal␣1-4Gal-mediated binding is also displayed by bacterial toxins, such as E. coli verotoxin (82, 83) , Shiga toxin produced by Shigella dysenteriae type 1 (84) , and staphylococcal enterotoxin-B (85). Gal␣1-4Gal␤1-3GalNAc, free or linked onto an O-glycoprotein, could be a good candidate to inhibit pathogen attachment (bacteria or toxins) to host cells.
Finally, this work shows the presence of a new ␣1,4-Gal-T activity in Mb cells responsible for the presence of the disaccharide epitope Gal␣1-4Gal onto endogenous Mb O-glycoproteins. Our results can be related to studies showing new glycosyltransferase activities in lepidopteran cells, as the ␤1,4-Nacetylgalactosaminyltransferase enzymatic activity in Tn, Sf-9, and Mb catalyzing the transfer of GalNAc residues to oligosaccharides carrying a terminal ␤-linked GlcNAc residue (86) or the ␣1,3-fucosyltransferase activity in Mb, which is able to transfer fucose into ␣1,3-linkage to the asparagine-bound GlcNAc residue of N-glycans (36) . Knowledge of these new insect glycosyltransferase activities will allow selection of the lepidopteran cell clones deficient in such activities for use in the production of recombinant glycoproteins. In addition, these new insect glycosylation potentials could represent an abundant source of enzymes for the biosynthesis of epitopes of potential therapeutic value. 
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